title: Agkistrodon piscivorus piscivorus platelet aggregation inhibitor: a potent inhibitor of platelet activation.
abstract: Applaggin (Agkistrodon piscivorus piscivorus platelet aggregation inhibitor) is a potent inhibitor of platelet activation. The protein is isolated from the venom of the North American water moccasin snake in three steps, including gel filtration, cation exchange, and reverse-phase HPLC procedures. The purified protein migrates as a 17,700-Da polypeptide by SDS/PAGE under nonreducing conditions and as a 9800-Da peptide in the presence of thiol. The behavior of applaggin on SDS/PAGE would indicate that the protein is a disulfide-linked dimer. Applaggin has been completely sequenced by Edman degradation and consists of 71 amino acids. The sequence is rich in cysteine and contains Arg-Gly-Asp at residues 50-52. Applaggin blocks platelet aggregation induced by ADP, collagen, thrombin, or arachidonic acid with IC50 values ranging from 12 to 128 nM (0.2-2.3 micrograms/ml) depending on the agonist and its concentration. This inhibition is found to correlate with inhibition of thromboxane A2 generation and of dense granule release of serotonin. Inhibition by applaggin of serotonin release induced by ADP, gamma-thrombin, and collagen was monitored in plasma under stirred conditions with [3H]serotonin-loaded platelets, and IC50 values for inhibition are found to range from less than 10 to 145 nM. At saturating concentrations, 125I-labeled applaggin (125I-applaggin) binds to 28,500 sites per unstimulated, washed platelet with a Kd of 1.22 x 10(-7) M. Binding of 125I-applaggin to platelets is inhibited by the synthetic undecapeptide Arg8-Gly-Asp-Val at 200 microM.
authors.affiliation: Biogen, Inc., Cambridge, MA 02142.
authors.forename: B H
authors.initials: BH
authors.lastname: Chao
authors.forename: J A
authors.initials: JA
authors.lastname: Jakubowski
authors.forename: B
authors.initials: B
authors.lastname: Savage
authors.forename: E P
authors.initials: EP
authors.lastname: Chow
authors.forename: U M
authors.initials: UM
authors.lastname: Marzec
authors.forename: L A
authors.initials: LA
authors.lastname: Harker
authors.forename: J M
authors.initials: JM
authors.lastname: Maraganore
mesh_terms: D000244:Adenosine Diphosphate / Q000494:pharmacology; D000595:Amino Acid Sequence; D000818:Animals; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects / Q000502:physiology*; D003094:Collagen / Q000494:pharmacology; D003435:Crotalid Venoms / Q000302:isolation & purification / Q000494:pharmacology*; D006801:Humans; D008969:Molecular Sequence Data; D010740:Phospholipases / Q000302:isolation & purification*; D010741:Phospholipases A / Q000097:blood / Q000302:isolation & purification* / Q000494:pharmacology; D015539:Platelet Activation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000302:isolation & purification*; D011485:Protein Binding; D012689:Sequence Homology, Nucleic Acid; D013917:Thrombin / Q000502:physiology
chemical_list: D001095:Arachidonic Acids; D003435:Crotalid Venoms; D010975:Platelet Aggregation Inhibitors; D016718:Arachidonic Acid; D000244:Adenosine Diphosphate; D003094:Collagen; D010740:Phospholipases; C041603:Agkistrodon platelet aggregation inhibitor; D010741:Phospholipases A; D013917:Thrombin